SCHEMBL9348453

SCHEMBL9348453

CCOC(=O)C(C)C(=O)c1ccccc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.50
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ GAA P10253 3/20 0.49
▸ HPGD P15428 1/20 0.49
▸ RECQL P46063 1/20 0.49
▸ CA12 O43570 2/20 0.47
▸ CA1 P00915 2/20 0.47
▸ CA2 P00918 2/20 0.47
▸ CA7 P43166 2/20 0.47
▸ CA9 Q16790 2/20 0.47
▸ CA14 Q9ULX7 2/20 0.47
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ TDP1 Q9NUW8 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ NPC1 O15118 2/20 0.45
▸ LMNA P02545 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3941262 0.84 TSHR (0.55) TSHRSMN1; SMN2CA2TDP1ALDH1A1
Catechol SCHEMBL27707731 0.84 CA12 (0.55) TSHRSMN1; SMN2GAAHPGDRECQL
SCHEMBL9345554 0.82 GAA (0.61) TSHRSMN1; SMN2GAAHPGDRECQL
SCHEMBL12947670 0.82 TSHR (0.49) TSHRHPGDMEN1KMT2AALDH1A1
SCHEMBL2125383 0.82 KDM4E (0.50) TSHRSMN1; SMN2GAAHPGDMEN1
SCHEMBL9344621 0.81 MAPT (0.49) TSHRSMN1; SMN2GAAHPGDMEN1
SCHEMBL18073921 0.81 HCRTR1 (0.53) TSHRGAAHPGDMEN1KMT2A
SCHEMBL5963646 0.80 TSHR (0.42) TSHRSMN1; SMN2GAAHPGDCA12
SCHEMBL9845817 0.78 TSHR (0.51) TSHRSMN1; SMN2GAAHPGDRECQL
SCHEMBL5866532 0.77 KMT2A (0.57) TSHRSMN1; SMN2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5292768-A Compound effective as cerebral insufficiency improver SUNTORY LIMITED (JP) 1994-03-08 — — US disclosed
US-5288752-A Brain disorders SUNTORY LIMITED (JP) 1994-02-22 — — US disclosed
EP-0322248-B1 COMPOUNDS EFFECTIVE AGAINST CEREBRAL INSUFFICIENCY SUNTORY LIMITED (JP) 1993-08-04 — — EP disclosed
US-5179092-A Cognition activators SUNTORY LIMITED (JP) 1993-01-12 — — US disclosed
US-5057514-A Compounds effective as cerebral schemia treating agents SUNTORY LIMITED (JP) 1991-10-15 — — US disclosed
EP-0322248-A2 Compounds effective against cerebral insufficiency SUNTORY LIMITED (JP) 1989-06-28 — — EP disclosed
Send feedback